- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Active Surveillance Might Work for Most With Prostate Cancer
A recent study published in European Urology highlights quality-of-life benefits with active surveillance in men with prostate cancer.
Men who opt for surveillance of their tend to have physical and mental wellbeing equal to or better than men who opt for immediate treatment, a new analysis suggests.
"The men in our study did not appear to suffer from any major negative psychological impacts, including and depression," said Dr. Lara Bellardita, the study's lead author from the IRCCS Foundation's National Cancer Institute in Milan, Italy.
Many men with prostate cancer will never need treatment for it, while about a third will go on to get treated after an average of two to three years of surveillance, said Dr. Marc A. Dall'Era, who wasn't involved with the new study but is a urologist at the University of California, Davis.
Link to the article in Medscape: http://bit.ly/1HuXGXs
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
